myHealthbox Adds Full Support for Healthcare Products Available in Australia, New Zealand and Brazil

Milano, Italy, November 25, 2013 --(PR.com)-- myHealthbox, the largest source of information on medicines and healthcare products, has today added support for medicines and healthcare product available in Australia, New Zealand and Brazil.

With these new additions the total number of countries supported is now 32 in 33 languages establishing myHealthbox as a global service serving millions of users on mobile and web platforms.

myHealthbox is also increasing the range of products supported adding information on veterinary, medical devices and plants protection products.

myHealthbox is the largest source of information on medicines and healthcare products promoting awareness, quality information and the safe use of healthcare products. myHealthbox provides access to up-to-date, reliable information on any device for over 1.5 million products available in 32 countries and 33 languages. myHealthbox also developed a new digital information leaflet format called eLeaflet specifically tailored at the healthcare.

myHealthbox is a solution for the design and distribution of an enhanced, digital version (eLeaflet) of the paper-based patient information leaflets commonly found in healthcare products packaging; myHealthbox provides an answer to both the consumers' and the healthcare industry's needs. Compared to the traditional paper-based leaflet the eLeaflet is fully multimedia enabled and allows the distribution of images, video and text without size or formats limitations.

The basic idea behind this is the need of establishing a direct channel between the producer and the consumer thus allowing the provisioning of a number of value added services such as: real time information and leaflets updates, direct marketing and DTCA (Direct To Consumer Advertising) through the use of advanced mobile devices (smartphones, tablets and eReaders).

The end result is not only the digitalization of a paper leaflet but a totally new concept with added search and navigation functionalities, enriched with full multimedia capabilities and distributed purely through digital channels. The actual content is product specific and totally customized but some parts are present in almost all products: a textual description of how best to use a medicine, information about the manufacturer and the helpline numbers, the adverse reaction form and the links to follow in order to obtain further information.

The advantages of such a solution are obvious: on the one side the consumer receives in a simple and effective way precise information about the medicines he/she is interested in and can navigate this information through a standardized paradigm; on the other side the producer can establish a direct link with its customers with clear advantages in terms of product safety, marketing and brand loyalty.

myHealthbox adopts a simple and straightforward process to communicate adverse reactions. Collected information is sent directly to the pharmaceutical company which will then follow up the case according to the specific country guidelines.

As with all medicinal content eLeaflet content follows the same approval route as other information related to medicines including the information included in the paper leaflets, the specific approval process is country specific.

myHealthbox information is updated in real-time and available through a number of devices and clients. The eLeaflet and related services are distributed via a generic web client or a dedicated client available for the most common mobile platforms.